Why bacteria derived R-M nucleic enzymatic peptides are likely efficient therapeutic molecules for use in the design and development of novel HIV inhibitory strategies

African Journal of Biotechnology

Volumn 7, Issue 12, 2008, Pages 1791-1796

  Misaki, Wayengera ^a  

^a MAKERERE UNIVERSITY   (Uganda)

Author keywords

Human immunodeficiency virus (HIV); Immune reconstitution; Methyltranferases (MTases); Probiotic microbicides; Restriction enzymes (REases RNases); Restriction modification (R M) systems

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; LENTIVIRUS VECTOR; METHYLTRANSFERASE; NUCLEIC ACID; PEPTIDE DERIVATIVE; PROBIOTIC AGENT; VIRUS DNA;

DNA BINDING; DNA PROTEIN COMPLEX; DNA REPLICATION; ENCAPSULATION; ENZYME MODIFICATION; HUMAN; HUMAN GENETICS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION PROCEDURE; NONHUMAN; PROTEIN RESTRICTION; REVIEW; RNA VIRUS; VIRUS CAPSID; VIRUS ENVELOPE; VIRUS GENE;

HUMAN IMMUNODEFICIENCY VIRUS; MIRIDAE; RNA VIRUSES;

EID: 46749154724     PISSN: None     EISSN: 16845315     Source Type: Journal    
DOI: 10.5897/ajb07.516     Document Type: Review

References (39)

1. Barcus VW, Murray N (1995). Barriers to recombination. In S. Baumberg, J Young, E Wellington and J Saunders(eds) Population genetics of bacteria; Cambridge University Press, Cambridge pp. 31-38.
2. Bor YC, Bushman F, Orgel L (1995). In vitro integration of human immunodeficiency virus type 1 cDNA into targets containing protein-induced bends. Proc. Natl. Acad. Sci. USA 92: 10334-10338.
3. Bushman FD (1994). Tethering human immunodeficiency virus 1 integrase to a DNA site directs integration to nearby sequences. Proc. Natl. Acad. Sci. USA 91: 9233-9237
4. Bushman FD, Craigie R (1992). Integration of human immunodeficiency virus DNA: adduct interference analysis of required DNA sites. Proc. Natl. Acad. Sci. USA 89: 3458-3462
5. Cochrane AW, McNally MT, Mouland AJ (2006). The retrovirus RNA trafficking granule: from birth to maturity. Retrovirol. Mar. 17. 3: 18.
6. Eduardo PC, Rocha AD, Alain V (2001). Evolutionary Role of Restriction/Modification Systems as Revealed by Comparative Genome Analysis GR, 11(6): 946-958. Wayengera 1795
7. Howard MT, Griffith JD (1993). A cluster of strong topoisomerase II cleavage sites is located near an integrated human immunodeficiency virus. J. Mol. Biol. 232: 1060-1068.
8. Human Genome Project (HGP) (2006). The Human genome. Available at http://www.ornl.gov/sci/techresources/Human_Genome/home.shtml
9. Janulaitis A, Petrusyte M, Maneliene Z, Klimasauskas S, Butkus V (1992). Purification and properties of Eco 57I restriction endonuclease and methylase, a prototype of a new class (type IV). Nucleic Acids Res. 20: 6043-6049.
10. Kessler C, Manta Y (1990). Specificity of restriction endonucleases and DNA modification methyltransferases, a review gene. Genete 92: 1-248.
11. Lepikhov K, Tchernov A, Zheleznaja L, Matvienko N, Walter J, Trautner TA (2001) .Characterization of the type IV restriction modification system BspLU11III from Bacillus sp. LU11 Nucleic Acids Res. 29(22):4691-4698(8).
12. Miura T, Sakuragi J, Kawamura M, Fukasawa M, Moriyama EN, Gojobori T, Ishikawa K, Mingle JA, Nettey VB, Akari H (1990). Establishment of a phylogenetic survey system for AIDS-related lentiviruses and demonstration of a new HIV-2 subgroup. AIDS. 12:1257-1261.
13. Muller HP, Varmus HE (1994). DNA bending creates favored sites for retroviral integration: an explanation for preferred insertion sites in nucleosomes. EMBO J. 13: 4704-4714.
14. Murray N (2002). Type 1 Restriction systems. Sophisticated Molecular Machines (a legacy of Bertani and Weigle). Microbial Mol. Biol. Rev. 64: 412-434.
15. Nelson M, McClelland M (1991). Site specific Methylation effect on DNA modification methyltransferases and restriction endonucleases. Nucleic Acids Res. 19: 2045-2071.
16. Nelson M, Yuan R, Heywood j (1972). Bacterial Restriction Modification systems. Ann. Rev. Biochem. 41: 447.
17. Noriko T, Yasuhiro N, Naofumi H, Ichizo K (2002). A DNA Methyltransferase Can Protect the Genome from Postdisturbance Attack by a Restriction- Modification Gene Complex. J. Bacteriol. 184(22): 6100-6108.
18. Peter AJ, Takai D (2001). The Role of DNA Methylation in Mammalian Epigenetics Science 293(5532): 1068-1070 DOI: 10.1126/science.1063852
19. Pruss D, Bushman FD, Wolffe AP (1994a). Human immunodeficiency virus integrase directs integration to sites of severe DNA distortion within the nucleosome core. Proc. Natl. Acad. Sci. USA 91: 5913-5917
20. Pruss D, Reeves R, Bushman FD, Wolffe AP (1994b). The influence of DNA and nucleosome structure on integration events directed by HIV integrase. J. Biol. Chem. 269: 25031-25041.
21. Pryciak P, Muller HP, Varmus HE (1992). Simian virus 40 minichromosomes as targets for retroviral integration in vivo. Proc. Natl. Acad. Sci. USA 89: 9237-9241.
22. Radasci NW, Bickle T (1996). DNA Restriction and modification. In Neidhort (ed) Escherchia coli, and salmonella. Cellular and molecular biology 2nd Edn: Am. Soc. Microbiol., Washington DC, pp. 773-781.
23. Restrizymes Corporation Canada (2007). Phase 1 clinical trial of VRXSMR -HIV therapeutic vaccine. Products in development. Available at www.restrizymes.com
24. Roberts RJ, Macelis D (1991). Restriction enzymes and their isoschizomes. Nuclei Acids Res. 1991: 2077-2109.
25. Sakai H, Sakuragi JI, Sakuragi S, Kawamura M, Adachi A (1993) Compatibility of Tat and Rev transactivators in the primate lentiviruses, Arch. Virol. Vol. 129, 1(4): 1-10.
26. Sakuragi J, Sakai H, Sakuragi S, Shibata R, Wain-Hobson S, Hayami M, Adachi A (1992). Functional classification of simian immunodeficiency virus isolated from a chimpanzee by transactivators. Virology. 189(1): 354-8.
27. Schneider J, Hunsmann G (1988). Simian lentiviruses - the SIV group. AIDS. 2(1): 1-9.
28. Scottoline BP, Chow S, Ellison, Brown PO (1997). Disruption of the terminal base pairs of retroviral DNA during integration. Genes Dev. 11: 371-382
29. Seguin B, Staffa A, Cochrane A (1998). Control of HIV-1 RNA Metabolism: The Role of Splice Sites and Intron Sequences in Unspliced Viral RNA Subcellular Distribution. J. Virol. 72: 9503-9513.
30. Stevens SW, Griffith JD (1994). Human immunodeficiency virus type 1 may preferentially integrate into chromatin occupied by L1Hs repetitive elements. Proc. Natl. Acad. Sci. USA 91: 5557-5561.
31. Stevens SW, Griffith JD (1996). Sequence analysis of the human DNA flanking sites of human immunodeficiency virus type 1 integration. J. Virol. 70: 6459-6462.
32. Suh D, Seguin B, Atkinson S, Ozdamar B, Staffa A, Cochrane A (2003). Mapping of the Determinants Required for Function of the Nuclear Retention Element Within HIV-1 Env. Virol. 310: 85-99.
33. Swenarchuk L, Harakidas P, Cochrane A (1999). Regulated expression of the Human Immunodeficiency Virus Type 1 rev protein in mammalian cell lines. Can. J. Microbiol. 45: 480-490.
34. Theresa LY, Chang C-HC , David AS, Qiang X (2003). Inhibition of HIV infectivity by a natural human isolate of Lactobacillus jensenii engineered to express functional two-domain CD4. Published online before print September 12, 2003, 10.1073/pnas.1934747100 PNAS, 100(20): 11672-11677.
35. Wayengera M (2005). Makerere Develops a Model for an AIDS Cure. www.aegis.org/news/nv/2005/NV050301.html.
36. th generation of Micro bicides for preventing HIV infection among high-risk women. Afr. J. Biotechnol. 6(10): 1221-1224
37. th June, (In Press).
38. Wayengera M (2007c). xREPLAB: A recombinant lactobacillus expressing restriction enzymes with potent activity against HIV 1 &2 for use a live Microbicide to prevent sexual transmission of HIV among high risk women AIDS Vaccine Aug 2007, Global HIV enterprise, Seattle, USA. Poster No. 106801.
39. Wayengera M, Byarugaba W, Kajjumbula H (2007). Frequency and site mapping of HIV-1/SIVcpz, HIV-2/SIVsmm and Other SIV gene sequence cleavage by various bacteria restriction enzymes: Precursors for a novel HIV inhibitory product. Accepted May 3rd 2007 Afr. J. Biotechnol. 6(10): 1225-1232.